Archives

Planning for a Talented Workforce: Building a Staffing Plan for New or Expanding GMP Facilities
Blog Post

Planning for a Talented Workforce: Building a Staffing Plan for New or Expanding GMP Facilities

Let’s contrast two very real scenarios: You are responsible for bringing a new GMP facility or line to full-scale production. Your board or shareholders expect...

Read More
Blog Post

LESSONS LEARNED FROM IMPLEMENTING THE FDA’s CSA GUIDANCE: PART 2– EXECUTING

This is the second in a series of three articles that present lessons that our validation team learned while completing a pair of validation projects...

Read More
Blog Post

Transformative Power of Virtual Twins (Part 3 of 3)

This is the final installment of a three-part series exploring the transformative power of Virtual Twins as part of an asset induction effort for facility...

Read More
Blog Post

Transformative Power of Virtual Twins (Part 2 of 3)

This is the second installment of a three-part series exploring the transformative power of Virtual Twins when applied to an asset induction effort for facility...

Read More
Blog Post

Transformative Power of Virtual Twins (Part 1 of 3)

This is the first installment of a three-part series exploring the transformative power of Virtual Twins when applied to an asset induction effort for facility...

Read More
Blog Post

Five Keys to Successful Facilities Management

Facilities Management is a critical aspect of maintaining a safe and efficient workplace. It involves a wide range of tasks, from maintaining the physical infrastructure...

Read More
Blog Post

LESSONS LEARNED FROM IMPLEMENTING THE FDA’s CSA GUIDANCE: PART 1 – PLANNING

After several years of conversation with drug manufacturers and consultants about the state of computer system validation, the FDA issued a draft of the Computer...

Read More
Blog Post

Remote Regulatory Assessments – Q&A: Here to Stay

On January 26, 2024, the Food and Drug Administration (FDA) provided notification of a revised draft guidance on Remote Regulatory Assessments (RRAs).  The FDA has...

Read More
Blog Post

The Future of FDA Regulatory Inspections:   

The Office of Regulatory Affairs (ORA) at the U.S. Food and Drug Administration (FDA) is currently buzzing with activity and exciting developments. Here's a snapshot...

Read More
Blog Post

Bridging the Gap: Role Clarity, Skill Investment, and the Battle Against Drug Shortages 

As advancements in medical science continue to expand the array of available treatments, the demand for pharmaceuticals has surged.  This surge has caused an alarming...

Read More